Table 1.
Correlation between the clinicopathologic characteristics and expression of GRP94 in breast cancer
| Characteristics | n | GRP94 expression | |||
|---|---|---|---|---|---|
|
| |||||
| High | Low | r | P value | ||
| Age (y) | |||||
| ≤45 | 67 | 30 (44.8%) | 37 (55.2%) | 0.484 | |
| >45 | 73 | 37 (50.7%) | 36 (49.3%) | ||
| TNM classification | |||||
| I-II | 129 | 59 (45.7%) | 70 (54.3%) | 0.085 | |
| III-VI | 11 | 8 (72.7%) | 3 (27.3%) | ||
| T classification | |||||
| T1-T2 | 126 | 61 (48.4%) | 65 (51.6%) | 0.693 | |
| T3-T4 | 14 | 6 (42.9%) | 8 (57.1%) | ||
| N classification | |||||
| N0-N1 | 95 | 45 (47.4%) | 50 (52.6%) | 0.866 | |
| N2-N3 | 45 | 22 (48.9%) | 23 (51.1%) | ||
| ER | |||||
| Negative | 47 | 27 (57.4%) | 20 (42.6%) | -0.136 | 0.106 |
| Positive | 93 | 40 (43.0%) | 53 (57.0%) | ||
| PR | |||||
| Negative | 56 | 33 (58.9%) | 23 (41.1%) | -0.181 | 0.032* |
| Positive | 84 | 34 (40.5%) | 50 (59.5%) | ||
*
Statistically significant.